Andrei Floroiu

2022

In 2022, Andrei Floroiu earned a total compensation of $3.6M as President and Chief Executive Officer at Biota Pharmaceuticals, a 49% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$133,125
Option Awards$2,481,765
Salary$532,500
Stock Awards$432,650
Other$9,352
Total$3,589,392

Floroiu received $2.5M in option awards, accounting for 69% of the total pay in 2022.

Floroiu also received $133.1K in non-equity incentive plan, $532.5K in salary, $432.7K in stock awards and $9.4K in other compensation.

Rankings

In 2022, Andrei Floroiu's compensation ranked 992nd out of 5,756 executives tracked by ExecPay. In other words, Floroiu earned more than 82.8% of executives.

ClassificationRankingPercentile
All
992
out of 5,756
83rd
Division
Manufacturing
462
out of 3,133
85th
Major group
Chemicals And Allied Products
166
out of 1,419
88th
Industry group
Drugs
149
out of 1,320
89th
Industry
Biological Products, Except Diagnostic Substances
36
out of 291
88th

Pay ratio

Andrei Floroiu's Pay$3,589,392
Median Employee's Pay$163,906
Pay Ratio

22

to 1

In 2022, the annual total compensation of Andrei Floroiu was $3,589,392.

The annual total compensation of the median employee at Biota Pharmaceuticals was $163,906.

The ratio of Andrei Floroiu's pay to the pay of median employee was therefore 22 to one.

Source: SEC filing on April 28, 2023.

Floroiu's colleagues

We found two more compensation records of executives who worked with Andrei Floroiu at Biota Pharmaceuticals in 2022.

2022

James Cummings

Biota Pharmaceuticals

Chief Medical Officer

2022

Sean Tucker

Biota Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like